Hepatitis C Stocks
3351 views
Rate Now: 1 2 3 4

average rating: 3.00 / 0 ratings
Created by Guest
DESCRIPTION:

Date updated:11-16-2006

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.

symbol name last price % change open
  • +
  • HGSI
    Human Genome Scie
  • $27.59
  • +0.07%
  • $27.24

Human Genome Sciences is developing a drug, Albuferon, that patients in a midstage trial of it are reporting better quality of life although it is at an early stage. They agreed to jointly market it with Swiss pharmaceutical giant Novartis but the risk is the late stage clinical trials could show it not to be as effective as investors hoped.

People owning HGSI also tend to own: ALXNAVNRBCRXCORDCGNDSCOEXEL

TheStreet.com Rating: D+ What is this?

  • +
  • IDIX
    Idenix Pharmaceut
  • $1.92
  • -2.04%
  • $2.00

Idenix Pharmaceuticals has partnered with Novartis on its drug, NM283. The drug has modest potency but is undergoing a trial in combination interferon and ribvirin that may show better results. Roche has a competing drug that may be more potent but it has to be given in higher doses. The trial for Idenix will hopefully clear things up.

People owning IDIX also tend to own: CAMPCEGEELNKFCELJBLUTALKTIE

TheStreet.com Rating: D- What is this?

  • +
  • ITMN
    Intermune
  • $13.56
  • -1.17%
  • $13.63

Intermune of Brisbane, CA has partnered with Swisds pharmaceutical titan Roche on several of its drugs. There have been no trials yet (one is planned for year end) so this is definitely speculative.

People owning ITMN also tend to own: AMMDARRYBVFCAHCBSTCELGCI

TheStreet.com Rating: D What is this?

  • +
  • SGP
    Sgp
  • $0.00
  • N/A
  • $N/A

Schering-Plough is an established playerin the treatment of Hepatitis C with a few different drugs which brought in 750M in sales last year. They have a few new drugs that are in development right now.

People owning SGP also tend to own: AMGNAPABACCCOPCVXDOW

TheStreet.com Rating: C+ What is this?

  • +
  • VRTX
    Vertex Pharmaceut
  • $39.22
  • +1.24%
  • $38.60

Vertex is the leader in the pack for drugs treating the virus. The small to mid-stage clinical trial results were spectacular. In June, the company signed a deal with Johnson & Johnson to codevelop the drug in which J&J obtained most foreign rights. Vertex shares have quadrupled over the past 2 years on optimism about its drug.

People owning VRTX also tend to own: EXPEIACIMCDXECHGSIIDIXITMN

TheStreet.com Rating: D- What is this?

  • +
  • VPHM
    Viropharma Incorp
  • $7.66
  • -1.67%
  • $7.68

In August, ViroPharma of Exton, PA said data from an early stage trial of its drug reduced the virus 99% after 14 days of treatment in combination with interferon.

People owning VPHM also tend to own: ASPVHANSESLRSLABAAPLAMGNBBY

TheStreet.com Rating: C- What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
Squeezing the Shorts: Late Earni...

By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...

11.04.09 | 15:18 PM
Cramer's Take on Headline Stocks...

By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...

11.04.09 | 11:12 AM
more articles
Banjo's Garden Pic Thread
05.10.09 | 12:33 PM From author banjoman
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
BIOTECH
07.26.09 | 11:32 AM From author CallaLilly
more forums
today 's lists
TheStreet.com TV Videos

These are some of the stocks mentioned on TheStreet.com TV on Sept. 2. Click the URL below each stock to watch the videos. more

Biggest % Gainers

Here are some of the largest % gainers from Nov. 2, 2009. more

Analyst Downgrades

Analyst Downgrades for Nov. 2, 2009. Read more here. more